Skip to content

HSCSW

HeartSciences Inc.

NASDAQ · Healthcare · Medical - Devices · US

$0.09
+20.96%
Ask drillr

Year over year

Reported trailing growth

Revenue
-27.7%
EBITDA
+99.5%
EBIT
-16.3%
EPS
+61.4%
Free cash flow
—
Operating cash flow
—

Forward estimates

Based on analyst estimates

Revenue
+4657.7%
EBITDA
+19.9%
EPS
+29.1%

Three-year CAGR

Revenue
-38.5%
EBITDA
+0.0%
EBIT
+0.0%
Net income
+0.0%
EPS
+0.0%
Free cash flow
+0.0%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026